Germline BAP1 mutations predispose to malignant mesothelioma JR Testa, M Cheung, J Pei, JE Below, Y Tan, E Sementino, NJ Cox, ... Nature genetics 43 (10), 1022-1025, 2011 | 1211 | 2011 |
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients RM Flores, HI Pass, VE Seshan, J Dycoco, M Zakowski, M Carbone, ... The Journal of thoracic and cardiovascular surgery 135 (3), 620-626. e3, 2008 | 721 | 2008 |
BAP1 and cancer M Carbone, H Yang, HI Pass, T Krausz, JR Testa, G Gaudino Nature Reviews Cancer 13 (3), 153-159, 2013 | 718 | 2013 |
Simian virus 40-like DNA sequences in human pleural mesothelioma. M Carbone, HI Pass, P Rizzo, M Marinetti, M Di Muzio, DJ Mew, ... Oncogene 9 (6), 1781-1790, 1994 | 554 | 1994 |
VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours Y Ohta, V Shridhar, RK Bright, GP Kalemkerian, W Du, M Carbone, ... British journal of cancer 81 (1), 54-61, 1999 | 510 | 1999 |
The pathogenesis of mesothelioma M Carbone, RA Kratzke, JR Testa Seminars in oncology 29 (1), 2-17, 2002 | 500 | 2002 |
Asbestos exposure, pleural mesothelioma, and serum osteopontin levels HI Pass, D Lott, F Lonardo, M Harbut, Z Liu, N Tang, M Carbone, C Webb, ... New England Journal of Medicine 353 (15), 1564-1573, 2005 | 484 | 2005 |
Malignant mesothelioma: facts, myths, and hypotheses M Carbone, BH Ly, RF Dodson, I Pagano, PT Morris, UA Dogan, ... Journal of cellular physiology 227 (1), 44-58, 2012 | 472 | 2012 |
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy M Carbone, PS Adusumilli, HR Alexander Jr, P Baas, F Bardelli, A Bononi, ... CA: a cancer journal for clinicians 69 (5), 402-429, 2019 | 447 | 2019 |
Cancer and inflammation: promise for biologic therapy S Demaria, E Pikarsky, M Karin, LM Coussens, YC Chen, EM El-Omar, ... Journal of immunotherapy 33 (4), 335-351, 2010 | 420 | 2010 |
BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation A Bononi, C Giorgi, S Patergnani, D Larson, K Verbruggen, M Tanji, ... Nature 546 (7659), 549-553, 2017 | 415 | 2017 |
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs M Carbone, LK Ferris, F Baumann, A Napolitano, CA Lum, EG Flores, ... Journal of translational medicine 10, 1-7, 2012 | 404 | 2012 |
TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis H Yang, M Bocchetta, B Kroczynska, AG Elmishad, Y Chen, Z Liu, ... Proceedings of the National Academy of Sciences 103 (27), 10397-10402, 2006 | 386 | 2006 |
Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma G Guo, J Chmielecki, C Goparaju, A Heguy, I Dolgalev, M Carbone, ... Cancer research 75 (2), 264-269, 2015 | 371 | 2015 |
High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma M Nasu, M Emi, S Pastorino, M Tanji, A Powers, H Luk, F Baumann, ... Journal of Thoracic Oncology 10 (4), 565-576, 2015 | 357 | 2015 |
Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey I Roushdy-Hammady, J Siegel, S Emri, JR Testa, M Carbone The Lancet 357 (9254), 444-445, 2001 | 345 | 2001 |
Simian virus-40 large-T antigen binds p53 in human mesotheliomas M Carbone, P Rizzo, PM Grimley, A Procopio, DJY Mew, V Shridhar, ... Nature medicine 3 (8), 908-912, 1997 | 335 | 1997 |
SV40 induces mesotheliomas in hamsters. C Cicala, F Pompetti, M Carbone The American journal of pathology 142 (5), 1524, 1993 | 333 | 1993 |
Mesothelioma epidemiology, carcinogenesis, and pathogenesis H Yang, JR Testa, M Carbone Current treatment options in oncology 9, 147-157, 2008 | 332 | 2008 |
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma HI Pass, SM Levin, MR Harbut, J Melamed, L Chiriboga, J Donington, ... New England Journal of Medicine 367 (15), 1417-1427, 2012 | 331 | 2012 |